Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine
April 13, 2021 at 13:46 PM EDT
Morgan Stanley believes J&J news could improve the 2022 outlook for mRNA vaccine makers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|